Aptar Pharma’s Unidose Nasal Spray system is the cornerstone of this innovative approach to nasal drug delivery, with millions of devices delivered to the market.
Proven Technology Partner
Aptar Pharma has decades of expertise supporting the development of Orally Inhaled and Nasal Drug Products (OINDPs) in FDA-regulated drug-device combination products across various therapeutic categories for chronic central nervous system (CNS) conditions, emergency use drugs and for local administration. Aptar Pharma’s Unidose liquid nasal spray system has been used with many customer references on the U.S. and European market.
Accurate and Precise Single-Dose Delivery
The Unidose system is designed to deliver one precise nasal spray dose every time for liquid formulations, without the need for priming or shaking before use, which makes it a user-friendly choice for caregivers, family members or patients themselves.
Advaspray®, Aptar Pharma’s new Unidose nasal spray system, provides for precise and consistent dosing, making it ideal for a wide range of applications, including therapies that require high deposition in target areas within the nasal cavity.